Company Overview of NeuroHealing Pharmaceuticals Inc.
NeuroHealing Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops drug treatments for specialty indications based on repositioning neurologically active compounds. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state; NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients; and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was incorporated in 2002 and is based in Newton, Massachusetts.
50 Undine Road
Unit No. 1
Newton, MA 02135
Founded in 2002
Key Executives for NeuroHealing Pharmaceuticals Inc.
NeuroHealing Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Yerba Prima, Inc.||United States|
|Pfanstiehl, Inc.||United States|
|ALTANA Pharma US, Inc.||United States|
|Concordia Pharmaceuticals Inc.||United States|
|Capricorn Pharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NeuroHealing Pharmaceuticals Inc., please visit www.neurohealing.com. Company data is provided by Capital IQ. Please use this form to report any data issues.